ABSTRACT
INTRODUCTION
Osteoarthritis is a chronic synovial joint disorder characterized by progressive softening and destruction of joint cartilage along with cartilage and bone growth in osteophytes, cyst formation and sclerosis in the bone subchondral, mild synovitis and fibrosis capsule. The disease is most common in middle-aged people, although young people may be affected as a result of injury [1] . Drugs commonly used for osteoarthritis treatment are pain relievers such as Non J. Islamic Pharm. 2018. 3 (1 Steroid Anti Inflammatory (NSAID). If the case has reached moderate to severe, it can be followed by glucosamine therapy, chondroitin sulfate or hyaluronidase acid that serves as a bone enhancer. In some cases, treatment with corticosteroids is also frequently performed [2] .
The increasing number of available drugs, drug users as well as more complex drug regimens leads to more side-effects and drug interactions that complicate treatment follow-up [3, 4] . Drug Related Problems (DRPs) or can also be called drug-related problems can be defined as an event or circumstance involving drug therapy that actually or potentially interfere with the desired therapeutic objective [5] . Cipolle categorized DRPs into 7 groups: non-treatment indications, drug selection inaccuracies, dose inaccuracies, unproven drugs, ADRs, inaccuracy of laboratory monitoring and patient disobedience [6, 7] . The most frequently of DRPs cases are ADRs, dose inaccuracies, and drug prescription that refer to insecure therapy [8] Dose inaccuracy can be caused by; doses too low or too high, blood levels of drugs above or below the range of therapy, frequency of administration, duration of therapy, and methods of administration of drugs are inappropriate, inappropriate prophylactic timing (e.g surgical prophylaxis given too early), and doses raised too fast [6] . ADRs can be caused by; anomaly response from patient (allergy to certain drug), anomaly response caused by coexistence, anomaly during presentation and administration of drug in patient body (occurrence of inappropriate bioavailability or medication administration method) and drug interaction [9] .
To prevent the case of DRPs, accurate control of drug therapy in patients is urgently needed, and this is one of the pharmacist's duties as a skilled healthcare professional. One of ways to control the accuracy of therapy is to review the accuracy of dosage and monitoring drug 
RESULTS AND DISCUSSION

Gender
The most respondents suffered osteoarthritis were women, about 68 people (78.16%) while men only 19 (21.84%).
Age
In this study, respondents who suffer from osteoarthritis are from the late adolescents, early adulthood, late adulthood, early old, elderly and oldest (see table 1 ).
BMI (Body Mass Index)
In this study, respondents with excess body weight (overweight) is quite high about 30 people while patient with obesity only 1 person, normal weight respondent about 55 people and underweight respondent only 1 person (see table 2 ).
Pain location ISSN : 2527-6123
The location of the joints most frequently affected by osteoarthritis is foot joint about 71 respondents (81.61%). Osteoarthritis hip only experienced by 4 people (4.60%) and 12 people (13.79%) experienced pain in other parts of body such as elbows, neck, hands and more than one joint.
Uric Acid Level
Respondents with high uric acid levels are about 5 people (5.75%), 21 people had normal uric acid levels (24.14%) and 61 people (70.1%) had unknown uric acid levels.
Diagnosis of Respondents
Respondents with uncomplicated diagnosis of OA are about 67 people (77.01%), 15
people had one comorbid disease (17.24%), 4 people had two comorbidities (4.60%) and 1 people had 3 comorbidities (1 , 15%) (see table 3 )
Drug Use Profile
The number of drugs given to outpatient OA respondents in RSUD Jombang in 2016 is at 
Dose inaccuracy
Respondents with an inaccurate dose on prescription are 72 people and respondent with accurate dose are 15 people. Based on total number of drugs received by respondents from 901 drugs, 214 drug was inappropriate dose and 687 drug was appropriate. From total 214 drugs, which 49 drugs were too high doses, 12 drugs were under dose, 118 drugs were high frequency and 35 drugs were low frequency. The most potent dose-induced drug is piroxicam (88 cases of high frequency) (see table 4 and 5 and figure 2 for graphic).
Adverse Drug Reactions
A total of 18 respondents (20.69%) experienced potential ADRs on prescriptions while 69 others (79.31%) did not. As for 292 total recipes, 23 recipes (7.88%) have potential ADRs and 269 recipes (92.12%) others did not. From 25 total cases were divided into 3 types of potential adverse drug interactions: NSAIDs + corticosteroids, NSAIDs + NSAIDs and paracetamol + ranitidine (see table 6 ). 
